Pacer BioThreat Strategy ETF
VIRS
VIRS was delisted on the 10th of October, 2024.
6 hedge funds and large institutions have $1.79M invested in Pacer BioThreat Strategy ETF in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.
50% more funds holding
Funds holding: 4 → 6 (+2)
11% more capital invested
Capital invested by funds: $1.6M → $1.79M (+$183K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$33.3K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$9.17K |
| 3 |
AF
Allworth Financial
Folsom,
California
|
+$4.57K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$24.9K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$15.8K |
| 3 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
-$11.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $749K | +$9.17K | +267 | +1% |
|
|
IAIM
2
International Assets Investment Management
Orlando,
Florida
| $671K | -$11.1K | -324 | -2% |
|
|
3
Osaic Holdings
Scottsdale,
Arizona
| $324K | -$15.8K | -459 | -5% |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $35K | +$33.3K | +969 | New |
|
|
AF
5
Allworth Financial
Folsom,
California
| $4.82K | +$4.57K | +133 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $3.04K | -$24.9K | -726 | -90% |
|
VIRS Hedge Fund Activity: Q1 2024 in Review
6 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Pacer BioThreat Strategy ETF (VIRS) for Q1 2024, worth a combined $1.79M — up 11% from $1.6M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new VIRS positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Royal Bank of Canada, opening a new position worth an estimated $33.3K. The largest seller was UBS Group, cutting an estimated $24.9K.
- 6 institutional investors held Pacer BioThreat Strategy ETF (VIRS) as of Q1 2024, up from 4 in Q4 2023.
- Funds reported $1.79M of Pacer BioThreat Strategy ETF stock for Q1 2024, up 11% quarter-over-quarter.
- 2 funds opened new Pacer BioThreat Strategy ETF positions in Q1 2024 and 0 closed out, a net change of +2 holders.
- The largest Pacer BioThreat Strategy ETF buyer in Q1 2024 was Royal Bank of Canada, an estimated $33.3K added.
- The largest Pacer BioThreat Strategy ETF seller in Q1 2024 was UBS Group, an estimated $24.9K sold.
Based on aggregated 13F filings for Q1 2024.